Do Older Patients with Metastatic Non-Small Cell Lung Cancer Also Benefit from First-Line Platinum-Based Doublet Chemotherapy?: Observations from a Pooled Analysis of 730 Prospectively-Treated Patients (Alliance Study A151622)

OBJECTIVE: This study sought to define the role of first-line platinum-based doublet chemotherapy in older non-small cell lung cancer (NSCLC) patients. METHODS: We analyzed three first-line NSCLC trials: CALGB 9730, CALGB 30203, and CALGB 30801, which tested carboplatin and paclitaxel; carboplatin a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Geriatr Oncol
Main Authors: Feliciano, Josephine L., Le-Rademacher, Jennifer G., Gajra, Ajeet, Edelman, Martin J., Zemla, Tyler, McMurray, Ryan, Chen, Hongbin, Hurria, Arti, Muss, Hyman, Cohen, Harvey J., Lilenbaum, Rogerio, Jatoi, Aminah
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233872/
https://ncbi.nlm.nih.gov/pubmed/29848457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2018.05.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados